

Resmetirom is the first approved therapy in the US specifically for MASH, earlier known as NASH—a progressive fatty liver disease linked to obesity, diabetes and poor metabolic health
Demand for vitamin and nutritional supplements is surging in India. This trend follows the increased availability of semaglutide-based weight-loss and diabetes medicines. Doctors are advising patients on these drugs to take multivitamins and protein supplemen…
Dr Reddys Laboratories has launched its oral semaglutide biosimilar for type 2 diabetes in India. The drug, Obeda, is available in three tablet strengths for daily use. This launch expands access to advanced diabetes care. Dr Reddys is the second Indian compa…

Dr. Reddy’s launches Obeda, an affordable oral semaglutide biosimilar for type 2 diabetes, enhancing treatment options in India.
Dr. Reddy's Laboratories proudly presents Obeda, a groundbreaking oral semaglutide biosimilar for managing Type 2 diabetes in India. This innovative treatment offers patients the ease of a once-daily oral dosage, available in various strengths to effectively …

Some Canadian pharmacists are already stocking their shelves with generic versions of semaglutide, more commonly known by the brand name Ozempic. But will these generics be just as good, and how much will the cost come down?
Prices for generic semaglutide, a popular weight-loss drug, are expected to fall by more than half in the coming months. This sharp decline is anticipated with the entry of smaller brands and a significant drop in raw material costs. The cost for a month's do…

The generic version of Ozempic from Canadian-based Apotex, has been approved, Health Canada said, adding that it was the second generic approved, even as seven applications were being reviewed

It'll probably take several years before generic semaglutide could arrive stateside.